To Order: patrick@cotinis.com
PD-L2 Peptide |
|||
4063P | ProSci | 0.05 mg | EUR 197.7 |
Description: (IN) PD-L2 peptide |
Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody |
|||
A64216-020 | EpiGentek | 20 ul | EUR 117.7 |
Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody |
|||
A64216-050 | EpiGentek | 50 ul | EUR 302.5 |
Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody |
|||
A64216-100 | EpiGentek | 100 ul | EUR 423.5 |
Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody |
|||
A64216 | EpiGentek |
|
|
PD-L2 Recombinant Protein |
|||
91-721 | ProSci | 0.05 mg | EUR 821.4 |
Description: Programmed Cell Death 1 Ligand 2 (PDCD1LG2) is a member of the BTN/MOG family. PDCD1LG2 contains one Ig-like C2-type domain and one Ig-like V-type domain. PDCD1LG2 is highly expressed in the heart, placenta, pancreas, lung and liver; it is weakly expressed in the spleen, lymph nodes, and thymus. PDCD1LG2 is involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. PDCD1LG2 interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production. |
PD-L2 Recombinant Protein |
|||
92-497 | ProSci | 0.05 mg | EUR 437.1 |
Description: Programmed cell death 1 ligand 2 (PD-L2), also known as butyrophilin B7-DC or PDCD1 ligand 2, belongs to the member of B7 family which can regulate the activation and tolerance of T cells. PD-L2 is one ligand for Programmed cell death 1(PD-1), and the other is PD-L1. These two ligands shares 34% aa sequence identity. Mouse PD-L2 gene encodes a 273 amino acids (aa) protein with a putative 19 aa signal peptide, a 201 aa extracellular region , a 21 aa transmembrane domain and a 32 aa cytoplasmic region. The mouse PD-L2 gene is highly expressed in heart, placenta, pancreas, lung and liver while expressed weakly in spleen, lymph nodes and thymus. Besides, the expression of PD-L2 gene can be induced on dendritic cells grown from peripheral blood mononuclear cells under CSF2 and IL4/interleukin-4 treatment, and up-regulated by IFNG/IFN-gamma stimulation in monocytes. PD-L2 usually functions in a PDCD1-independent manner and is involved in regulating costimulatory signal which is essential for T-cell proliferation and IFNG production. Recent studies demonstrate that the expression of PD-L2 on the tumor cells promotes CD8 T cell–mediated rejection of tumor cells, at both the induction and effector phase of antitumor immunity. Moreover, PD-L2 binds to PD-1 cells and enhances T cell killing in a PD-1–independent mechanism. |
PD-L2 Recombinant Protein |
|||
96-938 | ProSci | 0.1 mg | EUR 651.3 |
Description: Programmed cell death 1 ligand 2 (PD-L2 or PDCD1 ligand 2) is also known as Butyrophilin B7-DC, CD antigen CD273, which belongs to the immunoglobulin superfamily or BTN/MOG family. The expression of PD-L2 is up-regulated by IFNG/IFN-gamma stimulation in monocytes and induced on dendritic cells grown from peripheral blood mononuclear cells with CSF2 and IL-4. PD-L2 Involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. PD-L2 interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production. |
PD-L2 Recombinant Protein |
|||
97-021 | ProSci | 0.1 mg | EUR 651.3 |
Description: Programmed cell death 1 ligand 2 (PD-L2 or PDCD1 ligand 2) is also known as Butyrophilin B7-DC, CD antigen CD273, which belongs to the immunoglobulin superfamily or BTN/MOG family. The expression of PD-L2 is up-regulated by IFNG/IFN-gamma stimulation in monocytes and induced on dendritic cells grown from peripheral blood mononuclear cells with CSF2 and IL-4. PD-L2 Involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. PD-L2 interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production. |
PD-L2 Recombinant Protein |
|||
97-022 | ProSci | 0.1 mg | EUR 651.3 |
Description: Programmed cell death 1 ligand 2 (PD-L2 or PDCD1 ligand 2) is also known as Butyrophilin B7-DC, CD antigen CD273, which belongs to the immunoglobulin superfamily or BTN/MOG family. The expression of PD-L2 is up-regulated by IFNG/IFN-gamma stimulation in monocytes and induced on dendritic cells grown from peripheral blood mononuclear cells with CSF2 and IL-4. PD-L2 Involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. PD-L2 interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production. |
Ribosome-inactivating protein PD-L1/PD-L2 Antibody |
|||
1-CSB-PA306294LA01PJJ | Cusabio |
|
|
Description: A polyclonal antibody against Ribosome-inactivating protein PD-L1/PD-L2. Recognizes Ribosome-inactivating protein PD-L1/PD-L2 from Phytolacca dioica. This antibody is Unconjugated. Tested in the following application: ELISA |
Ribosome-inactivating protein PD-L1 / PD-L2 Antibody |
|||
20-abx319445 | Abbexa |
|
|
Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody, HRP Conjugated |
|||
A64217-050 | EpiGentek | 50 ul | EUR 302.5 |
Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody, HRP Conjugated |
|||
A64217-100 | EpiGentek | 100 ul | EUR 423.5 |
Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody, FITC Conjugated |
|||
A64218-050 | EpiGentek | 50 ul | EUR 302.5 |
Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody, FITC Conjugated |
|||
A64218-100 | EpiGentek | 100 ul | EUR 423.5 |
Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody, Biotin Conjugated |
|||
A64219-050 | EpiGentek | 50 ul | EUR 302.5 |
Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody, Biotin Conjugated |
|||
A64219-100 | EpiGentek | 100 ul | EUR 423.5 |
Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody, HRP Conjugated |
|||
A64217 | EpiGentek |
|
|
Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody, FITC Conjugated |
|||
A64218 | EpiGentek |
|
|
Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody, Biotin Conjugated |
|||
A64219 | EpiGentek |
|
|
Ribosome-inactivating protein PD-L1 / PD-L2 Antibody (HRP) |
|||
20-abx319446 | Abbexa |
|
|
Ribosome-inactivating protein PD-L1 / PD-L2 Antibody (FITC) |
|||
20-abx319447 | Abbexa |
|
|
Ribosome-inactivating protein PD-L1 / PD-L2 Antibody (Biotin) |
|||
20-abx319448 | Abbexa |
|
|
CD273 [PD-L2] Recombinant Protein |
|||
90-425 | ProSci | 100 ug | EUR 651.3 |
Description: T cells require a signal induced by the engagement of the T cell receptor and a costimulatory signal(s) through distinct T cell surface molecules for optimal T cell activation and tolerance. CD273 (PD-L2) is one of two ligands for programmed death-1 (PD-1; CD279), a member of the CD28 family of immunoreceptors. The other identified ligand is PD-L1. CD273 is broadly expressed and also up regulated in a variety of tumor cell lines. On previously activated T cells, CD273 interaction with PD-1 inhibits TCR mediated proliferation and cytokine production, suggesting an inhibitory role in regulating immune responses. CD273 has a costimulatory function on resting T cells activated with suboptimal TCR signals. |
CD273 [PD-L2] Recombinant Protein |
|||
90-427 | ProSci | 100 ug | EUR 651.3 |
Description: T cells require a signal induced by the engagement of the T cell receptor and a costimulatory signal(s) through distinct T cell surface molecules for optimal T cell activation and tolerance. CD273 (PD-L2) is one of two ligands for programmed death-1 (PD-1; CD279), a member of the CD28 family of immunoreceptors. The other identified ligand is PD-L1. CD273 is broadly expressed and also up regulated in a variety of tumor cell lines. On previously activated T cells, CD273 interaction with PD-1 inhibits TCR mediated proliferation and cytokine production, suggesting an inhibitory role in regulating immune responses. CD273 has a costimulatory function on resting T cells activated with suboptimal TCR signals. |
CD273 [PD-L2] Recombinant Protein |
|||
90-428 | ProSci | 100 ug | EUR 651.3 |
Description: T cells require a signal induced by the engagement of the T cell receptor and a costimulatory signal(s) through distinct T cell surface molecules for optimal T cell activation and tolerance. CD273 (PD-L2) is one of two ligands for programmed death-1 (PD-1; CD279), a member of the CD28 family of immunoreceptors. The other identified ligand is PD-L1. CD273 is broadly expressed and also up regulated in a variety of tumor cell lines. On previously activated T cells, CD273 interaction with PD-1 inhibits TCR mediated proliferation and cytokine production, suggesting an inhibitory role in regulating immune responses. CD273 has a costimulatory function on resting T cells activated with suboptimal TCR signals. |
Ribosome-inactivating protein PD-L1/PD-L2 Antibody, HRP conjugated |
|||
1-CSB-PA306294LB01PJJ | Cusabio |
|
|
Description: A polyclonal antibody against Ribosome-inactivating protein PD-L1/PD-L2. Recognizes Ribosome-inactivating protein PD-L1/PD-L2 from Phytolacca dioica. This antibody is HRP conjugated. Tested in the following application: ELISA |
Ribosome-inactivating protein PD-L1/PD-L2 Antibody, FITC conjugated |
|||
1-CSB-PA306294LC01PJJ | Cusabio |
|
|
Description: A polyclonal antibody against Ribosome-inactivating protein PD-L1/PD-L2. Recognizes Ribosome-inactivating protein PD-L1/PD-L2 from Phytolacca dioica. This antibody is FITC conjugated. Tested in the following application: ELISA |
Ribosome-inactivating protein PD-L1/PD-L2 Antibody, Biotin conjugated |
|||
1-CSB-PA306294LD01PJJ | Cusabio |
|
|
Description: A polyclonal antibody against Ribosome-inactivating protein PD-L1/PD-L2. Recognizes Ribosome-inactivating protein PD-L1/PD-L2 from Phytolacca dioica. This antibody is Biotin conjugated. Tested in the following application: ELISA |
Phytolacca dioica Ribosome-inactivating protein PD-L1/PD-L2 |
|||
1-CSB-EP306294PJJ | Cusabio |
|
|
Description: Recombinant Phytolacca dioica Ribosome-inactivating protein PD-L1/PD-L2 expressed in E.coli |
Mouse Anti-Human CD273 (PD-L2) mAbConjugated Antibody |
|||
CCM031 | SAB | 100ul | EUR 476.4 |
Anti-CD273/ PD-L2 Antibody [TY25], Unconjugated-100ug |
|||
QAB101-100ug | EnQuireBio | 100ug | EUR 270 |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
R32447 | NSJ Bioreagents | 100 ug | EUR 419 |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
V8176-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: Recognizes a protein of about 31kDa, which is identified as PD-L2 (same as PDCD1LG2). Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T cell proliferation, cytokine production, differentiation of effector T cells and the induction of Bcl-x, a promoter of T cell survival. Conversely, engagement of CTLA4 by B7-1 or B7-2 may inhibit proliferation and IL-2 production. PD-L2 does not bind CD28, cytotoxic T lymphocyte A4 or ICOS (inducible co-stimulator). The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the Pdcd-1-Pdcd-L system could provide unique negative signaling to help prevent autoimmune disease. |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
V8176-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: Recognizes a protein of about 31kDa, which is identified as PD-L2 (same as PDCD1LG2). Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T cell proliferation, cytokine production, differentiation of effector T cells and the induction of Bcl-x, a promoter of T cell survival. Conversely, engagement of CTLA4 by B7-1 or B7-2 may inhibit proliferation and IL-2 production. PD-L2 does not bind CD28, cytotoxic T lymphocyte A4 or ICOS (inducible co-stimulator). The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the Pdcd-1-Pdcd-L system could provide unique negative signaling to help prevent autoimmune disease. |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
V8176SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: Recognizes a protein of about 31kDa, which is identified as PD-L2 (same as PDCD1LG2). Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T cell proliferation, cytokine production, differentiation of effector T cells and the induction of Bcl-x, a promoter of T cell survival. Conversely, engagement of CTLA4 by B7-1 or B7-2 may inhibit proliferation and IL-2 production. PD-L2 does not bind CD28, cytotoxic T lymphocyte A4 or ICOS (inducible co-stimulator). The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the Pdcd-1-Pdcd-L system could provide unique negative signaling to help prevent autoimmune disease. |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
V7546-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: PD-L2/PDCD1LG2 is involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production. [UniProt] |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
V7546-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: PD-L2/PDCD1LG2 is involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production. [UniProt] |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
V7546SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: PD-L2/PDCD1LG2 is involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production. [UniProt] |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
V7581-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: Recognizes a protein identified as PD-L2 (same as PDCD1LG2). Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T cell proliferation, cytokine production, differentiation of effector T cells and the induction of Bcl-x, a promoter of T cell survival. Conversely, engagement of CTLA4 by B7-1 or B7-2 may inhibit proliferation and IL-2 production. PD-L2 does not bind CD28, cytotoxic T lymphocyte A4 or ICOS (inducible co-stimulator). The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the Pdcd-1-Pdcd-L system could provide unique negative signaling to help prevent autoimmune disease. |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
V7581-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: Recognizes a protein identified as PD-L2 (same as PDCD1LG2). Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T cell proliferation, cytokine production, differentiation of effector T cells and the induction of Bcl-x, a promoter of T cell survival. Conversely, engagement of CTLA4 by B7-1 or B7-2 may inhibit proliferation and IL-2 production. PD-L2 does not bind CD28, cytotoxic T lymphocyte A4 or ICOS (inducible co-stimulator). The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the Pdcd-1-Pdcd-L system could provide unique negative signaling to help prevent autoimmune disease. |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
V7581SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: Recognizes a protein identified as PD-L2 (same as PDCD1LG2). Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T cell proliferation, cytokine production, differentiation of effector T cells and the induction of Bcl-x, a promoter of T cell survival. Conversely, engagement of CTLA4 by B7-1 or B7-2 may inhibit proliferation and IL-2 production. PD-L2 does not bind CD28, cytotoxic T lymphocyte A4 or ICOS (inducible co-stimulator). The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the Pdcd-1-Pdcd-L system could provide unique negative signaling to help prevent autoimmune disease. |
Mouse Anti-Human CD273 (PD-L2) mAb |
|||
CM031-100ug | SAB | 100ug | EUR 250.8 |
Mouse Anti-Human CD273 (PD-L2) mAb |
|||
CM031-25ug | SAB | 25ug | EUR 154.8 |
CD273 [PD-L2] non-lytic Recombinant Protein |
|||
90-426 | ProSci | 100 ug | EUR 651.3 |
Description: T cells require a signal induced by the engagement of the T cell receptor and a €œcostimulatory€ signal(s) through distinct T cell surface molecules for optimal T cell activation and tolerance. CD273 is one of two ligands for programmed death-1 (PD-1; CD279), a member of the CD28 family of immunoreceptors. The other identified ligand is PD-L1. CD273 is broadly expressed and also up regulated in a variety of tumor cell lines. On previously activated T cells, CD273 interaction with PD-1 inhibits TCR mediated proliferation and cytokine production, suggesting an inhibitory role in regulating immune responses. CD273 has a costimulatory function on resting T cells activated with suboptimal TCR signals. |
PD-L2, Fc Chimera (HEK293-expressed), Human |
|||
HY-P7399 | MedChemExpress | 50ug | EUR 321.6 |
TranslationBlocker Human PD-L2/ CD273 siRNA, 10nmol |
|||
QX8-10nmol | EnQuireBio | 10nmol | EUR 452.4 |
TranslationBlocker Human PD-L2/ CD273 siRNA, 2nmol |
|||
QX8-2nmol | EnQuireBio | 2nmol | EUR 331.2 |
Recombinant PD-L2 Protein (Met1-Pro219) [His] |
|||
VAng-Cr3818-100g | Creative Biolabs | 100 µg | EUR 973.2 |
Description: Recombinant PD-L2 Protein (Met1-Pro219) fused with a His tag at C-terminus was expressed in Mammalian cells, with a molecular weight of 40-45 kDa. (Uniprot ID: Q9BQ51) |
L2 Polyclonal Antibody |
|||
A56895-020 | EpiGentek | 20 ul | EUR 117.7 |
L2 Polyclonal Antibody |
|||
A56895-050 | EpiGentek | 50 ul | EUR 302.5 |
L2 Polyclonal Antibody |
|||
A56895-100 | EpiGentek | 100 ul | EUR 423.5 |
L2 Polyclonal Antibody |
|||
A56907-020 | EpiGentek | 20 ul | EUR 117.7 |
L2 Polyclonal Antibody |
|||
A56907-050 | EpiGentek | 50 ul | EUR 302.5 |
L2 Polyclonal Antibody |
|||
A56907-100 | EpiGentek | 100 ul | EUR 423.5 |
L2 Polyclonal Antibody |
|||
A56895 | EpiGentek |
|
|
L2 Polyclonal Antibody |
|||
A56907 | EpiGentek |
|
|
Human PD-L2/B7-DC PicoKine ELISA Kit |
|||
EK1447 | BosterBio | 96 wells | EUR 510 |
Description: For Quantitative Detection of human PD-L2 in cell culture supernates, serum and plasma (heparin, EDTA). |
ELISA kit for Human PD-L2/B7-DC |
|||
EK5768 | SAB | 96 tests | EUR 663.6 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Human PD-L2/B7-DC in samples from serum, plasma, tissue homogenates and other biological fluids. |
Human CellExp? PD-L2 / B7-DC, mouse recombinant |
|||
P1087-10 | Biovision | EUR 170.4 |
Human CellExp? PD-L2 / B7-DC, mouse recombinant |
|||
P1087-50 | Biovision | EUR 548.4 |
Recombinant Human B7-DC/PD-L2/CD273 Protein |
|||
RP00150 | Abclonal | 20 μg | EUR 231.6 |
Recombinant Mouse PD-L2/B7-DC/CD273 Protein |
|||
RP00660 | Abclonal | 10 μg | EUR 174 |
Recombinant Human B7-DC/PD-L2/CD273 Protein |
|||
RP00988 | Abclonal | 10 μg | EUR 186 |
Polyclonal Apolipoprotein L2 Antibody |
|||
APR05494G | Leading Biology | 0.1ml | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Apolipoprotein L2 . This antibody is tested and proven to work in the following applications: |
Polyclonal PIWI-L2 Antibody |
|||
APR17843G | Leading Biology | 0.1 mg | EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PIWI-L2 . This antibody is tested and proven to work in the following applications: |
Polyclonal PIWI-L2 Antibody |
|||
APR17844G | Leading Biology | 0.1 mg | EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PIWI-L2 . This antibody is tested and proven to work in the following applications: |
PD-ECGF Polyclonal Antibody |
|||
ABP53145-003ml | Abbkine | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of PD-ECGF from Human. This PD-ECGF antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the N-terminal region of human PD-ECGF |
PD-ECGF Polyclonal Antibody |
|||
ABP53145-01ml | Abbkine | 0.1ml | EUR 346.8 |
Description: A polyclonal antibody for detection of PD-ECGF from Human. This PD-ECGF antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the N-terminal region of human PD-ECGF |
PD-ECGF Polyclonal Antibody |
|||
ABP53145-02ml | Abbkine | 0.2ml | EUR 496.8 |
Description: A polyclonal antibody for detection of PD-ECGF from Human. This PD-ECGF antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the N-terminal region of human PD-ECGF |
PD-ECGF Polyclonal Antibody |
|||
ES4144-100ul | ELK Biotech | 100ul | EUR 334.8 |
Description: A Rabbit Polyclonal antibody against PD-ECGF from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
PD-ECGF Polyclonal Antibody |
|||
ES4144-50ul | ELK Biotech | 50ul | EUR 248.4 |
Description: A Rabbit Polyclonal antibody against PD-ECGF from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
PD-ECGF Polyclonal Antibody |
|||
41799-100ul | SAB | 100ul | EUR 302.4 |
PD-ECGF Polyclonal Antibody |
|||
41799-50ul | SAB | 50ul | EUR 224.4 |
PD-1 Polyclonal Antibody |
|||
27584-100ul | SAB | 100ul | EUR 302.4 |
PD-1 Polyclonal Antibody |
|||
27584-50ul | SAB | 50ul | EUR 224.4 |
Polyclonal PD-1 Antibody |
|||
APR06440G | Leading Biology | 0.1 mg | EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PD-1 . This antibody is tested and proven to work in the following applications: |
Polyclonal PD-1 Antibody |
|||
APR06441G | Leading Biology | 0.1 mg | EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PD-1 . This antibody is tested and proven to work in the following applications: |
Recombinant Mouse PD-L2/B7-DC/CD273 (C-Fc) |
|||
CJ99-10ug | Novoprotein | 10ug | EUR 120 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
Recombinant Mouse PD-L2/B7-DC/CD273 (C-Fc) |
|||
CJ99-1mg | Novoprotein | 1mg | EUR 814.8 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
Recombinant Mouse PD-L2/B7-DC/CD273 (C-Fc) |
|||
CJ99-500ug | Novoprotein | 500ug | EUR 589.2 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
Recombinant Mouse PD-L2/B7-DC/CD273 (C-Fc) |
|||
CJ99-50ug | Novoprotein | 50ug | EUR 230.4 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
Mouse Anti-Human CD273 (PD-L2), FITC Conjugated mAb |
|||
CM032-100T | SAB | 100T | EUR 242.4 |
Mouse Anti-Human CD273 (PD-L2), FITC Conjugated mAb |
|||
CM032-25T | SAB | 25T | EUR 181.2 |
Mouse Anti-Human CD273 (PD-L2), PE Conjugated mAb |
|||
CM033-100T | SAB | 100T | EUR 494.4 |
Mouse Anti-Human CD273 (PD-L2), PE Conjugated mAb |
|||
CM033-25T | SAB | 25T | EUR 242.4 |
Mouse Anti-Human CD273 (PD-L2), Biotin Conjugated mAb |
|||
CM034-100ug | SAB | 100ug | EUR 416.4 |
Mouse Anti-Human CD273 (PD-L2), Biotin Conjugated mAb |
|||
CM034-25ug | SAB | 25ug | EUR 224.4 |
Recombinant Human PD-L2/B7-DC/CD273 (C-mFC) |
|||
CW20-10ug | Novoprotein | 10ug | EUR 175.2 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human PD-L2/B7-DC/CD273 (C-mFC) |
|||
CW20-1mg | Novoprotein | 1mg | EUR 2739.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human PD-L2/B7-DC/CD273 (C-mFC) |
|||
CW20-500ug | Novoprotein | 500ug | EUR 1935.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human PD-L2/B7-DC/CD273 (C-mFC) |
|||
CW20-50ug | Novoprotein | 50ug | EUR 363.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human PD-L2/B7-DC/CD273 (C-6His) |
|||
CA09-10ug | Novoprotein | 10ug | EUR 242.4 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human PD-L2/B7-DC/CD273 (C-6His) |
|||
CA09-1mg | Novoprotein | 1mg | EUR 2739.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human PD-L2/B7-DC/CD273 (C-6His) |
|||
CA09-500ug | Novoprotein | 500ug | EUR 1935.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human PD-L2/B7-DC/CD273 (C-6His) |
|||
CA09-50ug | Novoprotein | 50ug | EUR 595.2 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Human CellExp? CD273 / B7-DC / PD-L2, human recombinant |
|||
7369-10 | Biovision | EUR 294 |
Human CellExp? CD273 / B7-DC / PD-L2, human recombinant |
|||
7369-50 | Biovision | EUR 836.4 |
Recombinant Human PD-L2 Protein (aa 1-219) [Fc] |
|||
VAng-Cr4038-100g | Creative Biolabs | 100 µg | EUR 1364.4 |
Description: Recombinant Human PD-L2 Protein (Met1-Pro219) fused with a Fc tag at C-terminus was expressed in HEK293 Cells, with a molecular weight of 49.3 kDa. (Accession ID: NP_079515.2) |
Recombinant Human PD-L2 Protein (aa 1-219) [Fc] |
|||
VAng-Cr4038-200g | Creative Biolabs | 200 µg | EUR 2024.4 |
Description: Recombinant Human PD-L2 Protein (Met1-Pro219) fused with a Fc tag at C-terminus was expressed in HEK293 Cells, with a molecular weight of 49.3 kDa. (Accession ID: NP_079515.2) |
Recombinant Cynomolgus PD-L2 Protein (aa 1-219) [Fc] |
|||
VAng-Cr4039-100g | Creative Biolabs | 100 µg | EUR 1364.4 |
Description: Recombinant Cynomolgus PD-L2 Protein (Met1-Pro219) fused with a Fc tag at C-terminus was expressed in HEK293 Cells, with a molecular weight of 49.6 kDa. (Accession ID: A4GW30) |
Recombinant Cynomolgus PD-L2 Protein (aa 1-219) [Fc] |
|||
VAng-Cr4039-200g | Creative Biolabs | 200 µg | EUR 2024.4 |
Description: Recombinant Cynomolgus PD-L2 Protein (Met1-Pro219) fused with a Fc tag at C-terminus was expressed in HEK293 Cells, with a molecular weight of 49.6 kDa. (Accession ID: A4GW30) |
Recombinant Rat PD-L2 Protein (aa 1-219) [Fc] |
|||
VAng-Cr4040-100g | Creative Biolabs | 100 µg | EUR 1364.4 |
Description: Recombinant Rat PD-L2 Protein (Met1-Arg219) fused with a Fc tag at C-terminus was expressed in HEK293 Cells, with a molecular weight of 49.2 kDa. (Accession ID: NP_001101052.2) |
Recombinant Rat PD-L2 Protein (aa 1-219) [Fc] |
|||
VAng-Cr4040-200g | Creative Biolabs | 200 µg | EUR 2024.4 |
Description: Recombinant Rat PD-L2 Protein (Met1-Arg219) fused with a Fc tag at C-terminus was expressed in HEK293 Cells, with a molecular weight of 49.2 kDa. (Accession ID: NP_001101052.2) |
Recombinant Mouse PD-L2 Protein (aa 1-219) [Fc] |
|||
VAng-Cr4041-100g | Creative Biolabs | 100 µg | EUR 1232.4 |
Description: Recombinant Mouse PD-L2 Protein (Met1-Arg219) fused with a Fc tag at C-terminus was expressed in HEK293 Cells, with a molecular weight of 49.5 kDa. (Accession ID: Q9WUL5) |
Recombinant Mouse PD-L2 Protein (aa 1-219) [Fc] |
|||
VAng-Cr4041-200g | Creative Biolabs | 200 µg | EUR 2024.4 |
Description: Recombinant Mouse PD-L2 Protein (Met1-Arg219) fused with a Fc tag at C-terminus was expressed in HEK293 Cells, with a molecular weight of 49.5 kDa. (Accession ID: Q9WUL5) |
PD-L1 Rabbit pAb |
|||
A11273-100ul | Abclonal | 100 ul | EUR 369.6 |
PD-L1 Rabbit pAb |
|||
A11273-200ul | Abclonal | 200 ul | EUR 550.8 |
PD-L1 Rabbit pAb |
|||
A11273-20ul | Abclonal | 20 ul | EUR 219.6 |
PD-L1 Rabbit pAb |
|||
A11273-50ul | Abclonal | 50 ul | EUR 267.6 |
PD-1 Rabbit pAb |
|||
A11973-100ul | Abclonal | 100 ul | EUR 369.6 |
PD-1 Rabbit pAb |
|||
A11973-200ul | Abclonal | 200 ul | EUR 550.8 |
PD-1 Rabbit pAb |
|||
A11973-20ul | Abclonal | 20 ul | EUR 219.6 |
PD-1 Rabbit pAb |
|||
A11973-50ul | Abclonal | 50 ul | EUR 267.6 |
PD-L1 Rabbit mAb |
|||
A20270 | Abclonal | 20 μL | EUR 18 |
PD-L1 Rabbit mAb |
|||
A20344 | Abclonal | 20 μL | EUR 18 |
PD-L1 Rabbit pAb |
|||
A1645-100ul | Abclonal | 100 ul | EUR 369.6 |
PD-L1 Rabbit pAb |
|||
A1645-200ul | Abclonal | 200 ul | EUR 550.8 |